LOS ANGELES -- Wein Products Inc., a leading air purification manufacturer, announce their AS150MM device. This technology is designed to substantially repel, in indoor confined spaces, any airborne virus including SARS droplet nuclei or other toxic particle by means of an intense electrostatic force in the breathing zone.
The AS150MM is a small, pager-sized wearable battery operated ionic air purifier. When using the device, a substantial airborne germ exclusion zone will be created in front of the wearer's mouth, nose, and eyes. It does not matter the infectivity or the virulence of the germ; as long as the size is between .3 and 3 microns and it obeys the laws of electrostatics, gravitation, diffusion, and turbulence, the AS150MM offers protection.
"The results have been verified by leading world authorities under strict laboratory conditions," says inventor Stan Weinberg. "The technology has also been tested and recommended on Dateline NBC by The Good Housekeeping Institute."
SARS (Severe Acute Respiratory Syndrome) infection may spread not only by touch but also by viral coating on micro droplets expelled in human coughing, sneezing, talking and respiration to those nearby. According to the CDC, a surgical mask is helpful but does not stop all of the micro droplets from reaching the nose, mouth and eyes.
The Wein AS150MM has been extensively tested under strict laboratory conditions including aircraft cabin simulation by leading aerosol authorities and microbiologists at the University of Cincinnati School of Medicine.
Their toxic aerosol exposure assessment laboratories concluded that the Wein AS150MM could substantially reduce the concentration of toxic Aerosols from .3 to 3 microns, which are the respirable fraction that settles deep in the lungs to cause infection.
SARS-coated micro droplets are well within the tested particle size specification. The results were presented to the European Aerosol Conference in Leipzig, Germany and were published in the Journal of Aerosol Science seminar issue.
The Wein AS150MM creates a toxic particle exclusion zone in front of the wearer's mouth, nose and eyes. The unit substantially repels these charged particles including bacteria viral micro-droplets, dust, smoke, pollens, allergens or anything that is light enough to float in the air -- away from the breathing zone.
Considerable testing also indicates that the Wein AS150MM ionic space charge is a lethal environment for many types of germs so those that are not repelled may be killed before entering the breathing zone.
According to experts who peer-reviewed the studies, the physical concentration reduction does not depend on the infectivity of the particle as long as it is affected by the forces of electrostatics, diffusion, turbulence and gravity. It can be the most lethal pathogen known to man, it will still be controlled by these physical forces.
In addition, surgical masks may be coated with viral micro-droplets very near a user's mouth, nose and eyes whereas the Wein AS150MM repels these SARS micro-droplets or any aerosol away from the wearer and does not store infectious agents on the surface.
The mask also does not protect the eyes. For added protection, a surgical mask together with the Wein AS150MM could also be employed.
Disclaimer: Neither the Wein AS150MM nor any other germicidal protective technology can offer 100 percent protection against viral or bacterial infection. These germs can enter the body by touch contact, hand contamination, or food ingestion. Accordingly, Wein Products, Inc. does not guarantee the AS150MM will protect against SARS, especially since the wearer could have been infected by airborne SARS virus prior to use.
Source: Wein Products Inc.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
COVID-19 Realities: Beyond a Respiratory Virus, Addressing Optimism in Pandemic Management
February 28th 2024A recent commentary by Dr. Amesh Adalja in MedPage Today challenges the perception of COVID-19 as solely a respiratory virus, highlighting its broader impact on the body. This analysis questions the notion that COVID-19 should be managed like common respiratory infections, urging a closer look at vaccine effectiveness, the rise of long COVID, and the need for enhanced measures to curb the virus's spread. Let's explore the complexities of COVID-19 management and the pressing realities faced by the US and the world.